- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06136182
Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery
November 14, 2023 updated by: Methodist Health System
A descriptive comparative project will be conducted to determine if there is a difference in outcomes for adult patients requiring pericardial reconstruction using CorMatrix compared to Gentrix
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
A descriptive, comparative project will be conducted utilizing a retrospective chart review on patients at Methodist Mansfield Medical Center(MMMC) undergoing cardiac surgery requiring pericardial repair between the dates of January 1, 2017 through December 31, 2022.
The project will compare outcomes of a pre- and post-intervention following use of Gentrix ECM and the CorMatrix Extracellular Matrix(ECM) pericardial patch using information gathered from the patient's electronic health record (EHR).
The main outcome measures of post-operative Length of Stay(LOS), all-cause unplanned readmission within 30 days, and significant pleural effusion requiring thoracentesis within 30-days and 60 days as well as long-term (12 months) patient outcomes.
Study Type
Observational
Enrollment (Estimated)
489
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Loretta W Bedell, MPH
- Phone Number: 74680 214-947-4680
- Email: mhsirb@mhd.com
Study Contact Backup
- Name: Colette Ngo Ndjom, MS
- Phone Number: 71280 214-947-1280
- Email: MHSIRB@mhd.com
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Recruiting
- Methodist Dallas Medical Center
-
Contact:
- Colette Ngo Ndjom, MS
- Phone Number: 71280 214-947-4680
- Email: mhsirb@mhd.com
-
Contact:
- Loretta Bedell, MPH
- Phone Number: 74681 217-947-4681
- Email: mhsirb@mhd.com
-
Principal Investigator:
- Darien Bradford, MD
-
Sub-Investigator:
- Sheila Ford, DNP
-
Dallas, Texas, United States, 75203
- Recruiting
- Clinical Research Institute at Methodist Health System
-
Contact:
- Loretta W Bedell, MPH
- Phone Number: 74680 214-947-4680
- Email: lorettabedell@mhd.com
-
Contact:
- Colette Ngo Ndjom, MS
- Phone Number: 74681 410-947-4681
- Email: ColetteNgoNdjom@mhd.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
- Must have undergone a CABG or valve repair/replacement surgery requiring pericardial reconstruction.
- CABG or valve repair/replacement surgery must have been either elective or urgent status
Description
Inclusion Criteria:
- Must have undergone a Coronary Artery Bypass Grafting(CABG) or valve repair/replacement surgery requiring pericardial reconstruction.
CABG or valve repair/replacement surgery must have been either elective or urgent status
Exclusion Criteria:
-CABG or valve repair/replacement surgery classified as emergent status Surgery classified as redo-sternotomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative hospital LOS
Time Frame: 30 days
|
30-day all-cause unplanned readmissions after discharge
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Bachar, B and Manna, B. (2022, August 8). Coronary Artery Bypass Graft. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK507836/
- Rego A, Cheung PC, Harris WJ, Brady KM, Newman J, Still R. Pericardial closure with extracellular matrix scaffold following cardiac surgery associated with a reduction of postoperative complications and 30-day hospital readmissions. J Cardiothorac Surg. 2019 Mar 15;14(1):61. doi: 10.1186/s13019-019-0871-5.
- Valve repair or replacement (2022). In The Texas Heart Institute. https://www.texasheart.org/heart-health/heart-information-center/topics/valve-repair-or-replacement/
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 12, 2023
Primary Completion (Estimated)
May 12, 2024
Study Completion (Estimated)
May 12, 2024
Study Registration Dates
First Submitted
July 6, 2023
First Submitted That Met QC Criteria
November 14, 2023
First Posted (Estimated)
November 17, 2023
Study Record Updates
Last Update Posted (Estimated)
November 17, 2023
Last Update Submitted That Met QC Criteria
November 14, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 016.SUR.2023.M
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Study data or any protected health information will not be shared with anyone that is not delegated to the study.
The PI is committed to disseminate research results in a timely fashion.
Sharing of results generated by the data analysis during the course of the project will be through presentation at national scientific meetings and/or publication in open access journals.
All information obtained will be source de-identified and presented on a large scale and not traceable to any one particular individual.
IPD Sharing Time Frame
Data Might be available by 2024 for up to 4 years
IPD Sharing Access Criteria
All study-related documents will be retained by the clinical research institute (CRI) until at least three years after study completion or according to local laws, whichever is longer
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clinical Outcome of Pericardial Closure Using Gentrix
-
University of LouisvilleNorton HealthcareRecruitingOrgan Perfusion Determined by Using NIRS Post Transcatheter PDA Occlusion or Medical Closure of PDAUnited States
-
Imperial College LondonJoint Replacement Instrumented Orthopaedics LtdRecruitingFocus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip StemUnited Kingdom
-
Alexandria UniversityCompletedTo Evaluate the Clinical Outcome (Complications) of Emergency Endotracheal Intubation in Non-traumatic PatientsEgypt
-
Assiut UniversityCompletedDetection of Different Prognostic Factors and Their Relation With the Outcome | Using New Protocol to Prove the Role of N-acetyl Cysteine and Adequate Supportive Measures in Aluminum Phosphide Poisoning
-
University Hospital, EssenCompletedTachyarrhythmia | Clinical Outcome | Atypical Atrial Flutter | Induction of ArryhthmiaGermany
-
michal rollRecruitingSurgical Resection | The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an | Adjuvant Therapy on the Clinical Outcome of Patients With Desmoid Tumors AfterIsrael
Clinical Trials on Pericardial Closure Using Gentrix Following Cardiac Surgery
-
Karolinska InstitutetKarolinska University HospitalActive, not recruitingCardiac SurgerySweden
-
Aesculap AGB.Braun Surgical SACompletedCoronary Artery Disease | Aortic Valve Stenosis | Cardiac Valve InsufficiencySpain, Germany
-
Goethe UniversityRecruitingPost-interventional VJI Thrombi After CPBGermany
-
ClearFlow, Inc.Vanderbilt University Medical Center; Catholic Medical CenterCompletedHemorrhage | Atrial Fibrillation, PostoperativeUnited States
-
Prof. Dr. Theodor FischleinClearFlow, Inc.Unknown
-
SMART Clinical Products BVZiekenhuis Oost-LimburgCompletedVentricular Fibrillation | Ventricular TachycardiaBelgium
-
IMD Tech LtdUnknownGeneral Surgery | Oral DrynessIsrael
-
Soroka University Medical CenterUnknown
-
University College, LondonSociety for Cardiothoracic Surgery in Great Britain & Ireland; British Congenital...Unknown
-
German Breast GroupAstraZenecaCompletedBreast Cancer | Triple Negative Breast Neoplasms | HRpos Breast Neoplasms | BRCA 1 /2 and / or HRDGermany